Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages

Clinical and Experimental Immunology, Supplement

Volumn 104, Issue SUPPL. 1, 1996, Pages 10-20

  Andersson, J ^a,b   Skansen Saphir U ^a,c   Sparrelid, E ^a,b   Andersson, U ^a,c  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c ST GÖRAN S HOSPITAL   (Sweden)

Author keywords

Cytokines; Immune modulation; Immune responses; Intravenous immune globulin; Lymphoproliferation

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN;

ADULT; CONFERENCE PAPER; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOCYTOCHEMISTRY; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MACROPHAGE; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD3; BACTERIAL PROTEINS; CELLS, CULTURED; CYTOKINES; DOWN-REGULATION; EXOTOXINS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; LYMPHOKINES; MACROPHAGES; MEMBRANE PROTEINS; MONOCYTES; SIALOGLYCOPROTEINS; STREPTOCOCCUS; T-LYMPHOCYTES; TH1 CELLS; TH2 CELLS;

EID: 0029874260     PISSN: 09642536     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Ammann AJ, Ashman RF, Buckley RH. Use of intravenous gammaglobulin in antibody immunodeficiency: results of a multicenter controlled trial. Clin Immunol Immunopathol 1982; 22:60-9.
2. Imbach P, Barandun S, d'Apuzzo V et al. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1981; i:1228-32.
3. Newburger JW, Takahashi M, Burns JC et al. The treatment of Kawasaki syndrome with intravenous gammaglobulin. N Engl J Med 1986; 315:341-8.
4. Dalakas MC, Illa I, Dambrosia JD et al. A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med 1993; 329:121-8.
5. Dwyer JM. Manipulating the immune system with immune globulin. N Engl J Med 1992; 326:107-15.
6. Rosen FS. Putative mechanisms of the effect of intravenous γ globulin. Clin Immunol Immunopathol 1993; 67(Suppl):S41-9.
7. Dietrich G, Kaveri S-V, Kazatchkine MD. Modulation of autoimmunity by intravenous immune globulin through interaction with the function of the immune/idiotypic network. Clin Immunol Immunopathol 1992; 62(Suppl):S73-81.
8. Arend WP, Josin FG, Massoni RJ. Effects of immune complexes on production by human monocytes of interleukin-1 or an interleukin-1 inhibitor. J Immunol 1985; 134:3868-74.
9. Poutsiaka DD, Clark D, Vannier E et al. Production of interleukin-1 receptor antagonist and interleukin-1β by peripheral blood mononuclear cells is differentially regulated. Blood 1991; 78:1275-83.
10. Aukrust P, Froland SS, Liabakk N-B et al. Release of cytokines, soluble cytokine receptors, and interleukin-1 receptor antagonist after intravenous immunoglobulin administration in vivo. Blood 1994; 84:2136-43.
11. Leung DYM, Kurt-Jones E, Newburger JW et al. Endothelial cell activation of high IL-1 secretion in the pathogenesis of acute Kawaski disease. Lancet 1989; ii:1298-305.
12. Kuhnert P, Schalch L, Jungi TW. Cytokine induction in human mononuclear cells stimulated by IgG-coated culture surfaces and by IgG for infusion. Clin Immunol Immunopathol 1990; 57:218-28.
13. Iwata M, Shimozato R, Tokiwa H, Tsubura E. Antipyretic activity of human immunoglobulin preparations for intravenous use in an experimental model of fever in rabbits. Infect Immun 1987; 55:547-55.
14. Shimozato T, Iwata M, Tamura N. Suppression of TNFα production by a human immunoglobulin preparation for intravenous use. Infect Immun 1990; 58:1384-94.
15. Takei S, Arora YK, Walker SM. Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens. J Clin Invest 1993; 91:60-8.
16. Amran D, Renz II, Lack G et al. Suppression of cytokine-dependent human T-cell proliferation by intravenous immunoglobulin. Clin Immunol Immunopathol 1994; 73:180-6.
17. Toyoda M, Zhang X, Petrosian A et al. Modulation of immunoglobulin production and cytokine mRNA expression in peripheral blood mononuclear cells by intravenous immunoglobulin. J Clin Immunol 1994; 14:178-89.
18. Marchalonis JJ, Schluter SF, Wang E et al. Synthetic autoantigens of immunoglobulins and T-cell receptors: their recognition in aging, infection, and autoimmunity. Proc Soc Exp Biol Med 1994; 207:129-47.
19. Klaesson S, Ringdén O, Markling L et al. Immune modulatory effects of immunoglobulins on cell-mediated immune responses in vitro.Scand J Immunol 1993; 38:477-87.
20. Sander B, Andersson J, Andersson U. Assessment of cytokines by immunofluorescence and the paraformaldehyde saponin procedure. Immunol Rev 1991; 119:65-93.
21. Sasaki H, Pollard RB, Schmitt D, Suzuki F. Short analytical review: Transforming growth factor-β in the regulation of the immune response. Clin Immunol Immunopathol 1992; 65:1-9.
22. Schalch L, Rordorf-Adam C, Dasch JR et al. IgG stimulated and LPS stimulated monocytes elaborate transforming growth factor β (TGF-β) in active form. Biochem Biophys Res Comm 1991; 174:885-95.
23. Kelso A. Frequency analysis of lymphokine secreting CD4+ and CD8+ T cells activated in a graft-versus-host reaction. J Immunol 1990; 145:2167-74.
24. Stevens DL, Tanner M, Winship J et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 1989; 321:1-11.
25. Skansén-Saphir U, Andersson J, Andersson U. Lymphokine production induced by streptococcal pyrogenic exotoxin-A is selectively downregulated by pooled human IgG. Eur J Immunol 1994; 24:916-22.
26. Björk L, Andersson U, Chauvet JM et al. Quantification of superantigen induced IFN-γ production by computerized image analysis - inhibition of cytokine production and blast transformation by pooled human IgG. J Immunol Methods 1994; 175:201-13.
27. Montanaro A, Pirofsky B. Prolonged interval high-dose intravenous immunoglobulin in patients with primary immunodeficiency states. Am J Med 1984; 76:67-78.
28. Dolhain RJ, Andersson U, ter Haar NT et al. Detection of intracellular IFN-γ by light microscopy using an immunoperoxidase technique: correlation with the corresponding mRNA and protein product. J Leukoc Biol 1993; 54:545-51.
29. Andersson J, Björk L, Dinarello C, Andersson U. Lipopolysaccharide induces human Interleukin 1 receptor antagonist and Interleukin-1 production in the same cell. Eur J Immunol 1992; 22:2617-23.
30. Andersson JP, Andersson U. Human intravenous immunoglobulin modulates monokine production in vitro. Immunology 1990; 71: 372-76.
31. Bussel J, Pahwa S, Forges A et al. Correlation of in vitro antibody synthesis with the outcome of intravenous gammaglobulin treatment of chronic idiopathic thrombocytopenic purpura. J Clin Immunol 1986; 6:50-9.
32. Hirano T, Yasukawa K, Harada H et al. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 1986; 324:73-5.
33. Andersson U, Andersson J, Lindfors A et al. Simultaneous production of interleukin-2, interleukin-4 and IFN-γ by human blood lymphocytes. Eur J Immunol 1990; 20:1591-6.
34. Stegmayr B, Björk S, Holm S et al. Septic shock induced by group A streptococcal infection: clinical and therapeutic aspects. Scand J Infect Dis 1992; 24:589-96.
35. Roux KH, Tankersley DL. A view of the human idtotypic repertoire. Electron microscopic and immunologic analyses of spontaneous idiotype-anti-idiotype dimers in pooled human IgG. J Immunol 1990; 144:1387-95.